Scrutinizer''s report and Outcome of AGM

Vista Pharmaceuticals held its 34th Annual General Meeting on September 30, 2025, via video conferencing from 11:00 AM to 11:26 AM, with 72 members in attendance. All 8 resolutions on the agenda were passed, including adoption of the audited financial statements for FY25, re-appointment of two retiring independent directors (Mr. Divakar Reddy Yerrabommanahalli and Mr. Umakanth Katta), re-appointment of Statutory Auditors, appointment of M/s. Aakanksha Dubey & Co. as Secretarial Auditors for 5 years, and re-appointment of Mr. Murali Meraga as Managing Director and Mr. Pavan Sathvik Gilaka and Dr. Dhananjaya Alli as Whole-time Directors. Shareholders voted overwhelmingly in favor, with 98.74% (94.37 lakh shares) supporting the resolutions and only 1.26% (1.20 lakh shares) against, on a modest 15.53% voting turnout of total outstanding shares. The Scrutinizer, M/s. Aakanksha Dubey & Co., certified that all resolutions were passed with the requisite majority.